BTW
Boston Trust Walden Portfolio holdings
AUM
$14B
1-Year Return
12.58%
This Quarter Return
+3.19%
1 Year Return
+12.58%
3 Year Return
+52.97%
5 Year Return
+115.22%
10 Year Return
+284.47%
AUM
$6.19B
AUM Growth
–
Cap. Flow
+$6.19B
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
11.07%
Holding
316
New
316
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
W.W. Grainger
GWW
|
$79.8M |
| 2 |
Exxon Mobil
XOM
|
$79.4M |
| 3 |
T Rowe Price
TROW
|
$76M |
| 4 |
SIVB
SVB Financial Group
SIVB
|
$71M |
| 5 |
Donaldson
DCI
|
$67.1M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Financials | 16.48% |
| 2 | Technology | 14.57% |
| 3 | Industrials | 13.73% |
| 4 | Consumer Discretionary | 12.38% |
| 5 | Healthcare | 11.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
VF Corp
VFC
$5.8B
| $396K | 0.01% |
+8,708
| New | +$396K |
|
277
Caterpillar
CAT
$199B
| $388K | 0.01% |
+4,708
| New | +$388K |
|
|
EPAY
278
DELISTED
Bottomline Technologies Inc
EPAY
| $384K | 0.01% |
+15,150
| New | +$384K |
|
279
Rockwell Automation
ROK
$38.2B
| $374K | 0.01% |
+4,500
| New | +$374K |
|
|
DD
280
DELISTED
Du Pont De Nemours E I
DD
| $369K | 0.01% |
+7,410
| New | +$369K |
|
281
Southern Company
SO
$101B
| $366K | 0.01% |
+8,300
| New | +$366K |
|
282
Murphy Oil
MUR
$3.52B
| $349K | 0.01% |
+6,630
| New | +$349K |
|
283
Edgewell Personal Care
EPC
$1.08B
| $335K | 0.01% |
+4,498
| New | +$335K |
|
284
Vanguard Real Estate ETF
VNQ
$34.6B
| $321K | 0.01% |
+4,675
| New | +$321K |
|
285
Ingredion
INGR
$8.23B
| $318K | 0.01% |
+4,840
| New | +$318K |
|
|
PDCO
286
DELISTED
Patterson Companies, Inc.
PDCO
| $318K | 0.01% |
+8,450
| New | +$318K |
|
287
Novartis
NVS
$250B
| $314K | 0.01% |
+4,957
| New | +$314K |
|
288
Moody's
MCO
$89.5B
| $313K | 0.01% |
+5,130
| New | +$313K |
|
289
Honeywell
HON
$136B
| $312K | 0.01% |
+4,126
| New | +$312K |
|
290
Thermo Fisher Scientific
TMO
$186B
| $307K | 0.01% |
+3,625
| New | +$307K |
|
291
Norfolk Southern
NSC
$62.3B
| $303K | ﹤0.01% |
+4,175
| New | +$303K |
|
|
CATC
292
DELISTED
CAMBRIDGE BANCORP
CATC
| $295K | ﹤0.01% |
+7,500
| New | +$295K |
|
293
Idexx Laboratories
IDXX
$51.7B
| $287K | ﹤0.01% |
+6,400
| New | +$287K |
|
294
Amgen
AMGN
$153B
| $286K | ﹤0.01% |
+2,900
| New | +$286K |
|
295
Eaton
ETN
$136B
| $284K | ﹤0.01% |
+4,314
| New | +$284K |
|
296
NextEra Energy, Inc.
NEE
$145B
| $277K | ﹤0.01% |
+13,600
| New | +$277K |
|
297
Parker-Hannifin
PH
$96B
| $265K | ﹤0.01% |
+2,775
| New | +$265K |
|
298
Marsh & McLennan
MMC
$100B
| $263K | ﹤0.01% |
+6,600
| New | +$263K |
|
299
Teva Pharmaceuticals
TEVA
$21.6B
| $251K | ﹤0.01% |
+6,400
| New | +$251K |
|
300
Henry Schein
HSIC
$8.39B
| $249K | ﹤0.01% |
+6,630
| New | +$249K |
|